Highlight Therapeutics
3 known investors
Find your way into Highlight Therapeutics
Sign up to see every warm intro you have to Highlight Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Highlight Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Highlight Therapeutics is a biotech company developing therapeutic treatments. The page does not provide specific details about the company's focus area, customer base, or geographic market.
Founders & leadership
MQ

Marisol QuinteroChief Operating Officer (former CEO 2013-2025)Marisol Quintero is Chief Operating Officer at Highlight Therapeutics, a biotech company developing therapeutic treatments; she previously served as CEO from 2013 to 2025 and has experience in life sciences technology evaluation, intellectual asset management, and business development.
Investors · 3
Buenavista Equity Partnerslisted by Buenavista Equity PartnersMadrid
How we know: Buenavista Equity Partners's portfolio page · funding news · buenavistaequity.com · Not right? Tell us
Droia Ventureslisted by Droia VenturesLuxembourg · $540K
How we know: Droia Ventures's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Columbus Venture PartnersreportedValenciavia Jose Mesa · inferred
How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
In the news
Frequently asked questions
- What does Highlight Therapeutics do?
- Highlight Therapeutics is a biotech company developing therapeutic treatments. The page does not provide specific details about the company's focus area, customer base, or geographic market.
- Who are Highlight Therapeutics's investors?
- Highlight Therapeutics's investors include Buenavista Equity Partners, Droia Ventures, Columbus Venture Partners.

